Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$56,215,836
-$15,017,134 QoQ
Shares Held
229,668
-45.5% QoQ
Ownership
0.438%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 500 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Derivatives in AXSM
reported options exposure · as of Jun 30, 2025CallValue
$229,658
CallShares
2,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. AXSM ranks #60 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in AXSM
Export CSV
33 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,215,836 | 229,668 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $71,232,970 | 421,447 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $54,957,470 | 300,906 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $27,221,680 | 224,139 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $229,658 | 2,200 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $23,822,212 | 228,204 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $35,189,369 | 301,718 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $18,408,343 | 217,567 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $32,589,108 | 362,625 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $32,306,823 | 401,327 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $23,270,637 | 291,612 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,817,486 | 35,400 | Put | Defined | 2024-05-14 | |
| 2023-12-31 | $16,380,814 | 205,815 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $2,474,106 | 35,400 | Put | Defined | 2024-05-15 | |
| 2023-09-30 | $11,129,912 | 159,249 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $10,056,015 | 139,939 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $16,611,657 | 269,320 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $1,558,026 | 20,200 | Put | Defined | 2024-05-14 | |
| 2022-12-31 | $20,504,161 | 265,839 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $23,169,559 | 519,264 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $14,452,006 | 377,337 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $2,406,289 | 58,137 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,024,288 | 80,050 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,440,648 | 43,709 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $2,835,208 | 42,028 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,079,106 | 142,690 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $14,485,039 | 177,796 | Shares | Defined | 2021-02-12 | |
| 2020-12-31 | $1,629,400 | 20,000 | Put | Defined | 2021-02-12 | |
| 2020-09-30 | $23,545,060 | 330,457 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $34,245,758 | 416,210 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $423,576 | 7,200 | Put | Defined | 2020-05-15 | |
| 2020-03-31 | $12,943,011 | 220,007 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $1,088,355 | 18,500 | Call | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||